HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoying Zhang Selected Research

IgY

2/2022Specific anti-SARS-CoV-2 S1 IgY-scFv is a promising tool for recognition of the virus.
9/2020Canine Parvovirus is diagnosed and neutralized by chicken IgY-scFv generated against the virus capsid protein.
12/2016Preparation of chicken IgY against recombinant E2 protein of bovine viral diarrhea virus (BVDV) and development of ELISA and ICA for BVDV detection.
1/2014Effect of chicken egg yolk antibodies (IgY) against diarrhea in domesticated animals: a systematic review and meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoying Zhang Research Topics

Disease

75Neoplasms (Cancer)
06/2022 - 06/2007
17Inflammation (Inflammations)
11/2022 - 06/2008
13Neoplasm Metastasis (Metastasis)
05/2022 - 05/2009
12Carcinogenesis
03/2022 - 06/2007
12Insulin Resistance
01/2022 - 08/2004
12Hepatocellular Carcinoma (Hepatoma)
11/2021 - 05/2005
9Pancreatitis
07/2022 - 01/2017
9Infections
01/2022 - 01/2016
9Lymphatic Metastasis
12/2019 - 07/2007
8Breast Neoplasms (Breast Cancer)
06/2022 - 05/2009
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 07/2007
8Body Weight (Weight, Body)
10/2021 - 03/2010
8Hypertrophy
01/2021 - 03/2011
8Hyperglycemia
01/2019 - 07/2007
7Bronchopulmonary Dysplasia
11/2022 - 07/2011
7Hypoxia (Hypoxemia)
04/2022 - 01/2012
7Esophageal Neoplasms (Esophageal Cancer)
12/2021 - 05/2010
7Necrosis
01/2021 - 09/2007
7Leukemia
12/2020 - 09/2015
7Atherosclerosis
12/2020 - 02/2008
7Skin Neoplasms (Skin Cancer)
06/2012 - 01/2008
6Parkinson Disease (Parkinson's Disease)
01/2022 - 11/2013
6Type 2 Diabetes Mellitus (MODY)
01/2021 - 09/2006
6Melanoma (Melanoma, Malignant)
12/2018 - 08/2010
5Obesity
01/2022 - 01/2012
5Cardiomegaly (Heart Hypertrophy)
01/2021 - 02/2013
5Esophageal Squamous Cell Carcinoma
01/2020 - 09/2014
5Heart Failure
09/2016 - 09/2007
4Stroke (Strokes)
05/2022 - 01/2016
4Colorectal Neoplasms (Colorectal Cancer)
04/2022 - 01/2009
4COVID-19
02/2022 - 11/2020
4Cognitive Dysfunction
01/2022 - 01/2014
4Lung Neoplasms (Lung Cancer)
01/2021 - 11/2016
4Coronary Artery Disease (Coronary Atherosclerosis)
04/2014 - 12/2009
3Hyperoxia
11/2022 - 07/2011
3Hyperlipidemias (Hyperlipidemia)
07/2022 - 08/2004
3Myocardial Infarction
05/2022 - 05/2012
3Multiple Myeloma
05/2022 - 01/2018
3Rheumatoid Arthritis
01/2022 - 04/2015
3Chronic Obstructive Pulmonary Disease (COPD)
01/2022 - 12/2017
3Abdominal Aortic Aneurysm
01/2022 - 11/2006
3Edema (Dropsy)
01/2022 - 10/2016
3Carcinoma (Carcinomatosis)
01/2021 - 01/2018
3Neuroinflammatory Diseases
01/2021 - 11/2019
3Ischemia
01/2021 - 10/2016
3Alzheimer Disease (Alzheimer's Disease)
05/2020 - 01/2014
3Psoriasis (Pustulosis Palmaris et Plantaris)
02/2020 - 04/2010
3Adenoviridae Infections (Adenovirus Infections)
01/2018 - 09/2016
3Oropharyngeal Neoplasms
01/2018 - 01/2016
3Liver Diseases (Liver Disease)
01/2015 - 07/2008
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2014 - 03/2009

Drug/Important Bio-Agent (IBA)

30Proteins (Proteins, Gene)FDA Link
04/2022 - 07/2007
16Biomarkers (Surrogate Marker)IBA
11/2022 - 09/2013
16MicroRNAs (MicroRNA)IBA
11/2022 - 06/2007
16Messenger RNA (mRNA)IBA
11/2022 - 07/2007
16Apolipoproteins MIBA
12/2020 - 05/2005
11Pharmaceutical PreparationsIBA
07/2022 - 10/2011
9AntioxidantsIBA
04/2022 - 01/2016
9CytokinesIBA
01/2022 - 04/2015
9Glucose (Dextrose)FDA LinkGeneric
01/2022 - 05/2010
7LipidsIBA
01/2022 - 02/2008
6Interleukin-6 (Interleukin 6)IBA
03/2021 - 11/2009
6LipopolysaccharidesIBA
12/2020 - 01/2016
5Adenosine Triphosphate (ATP)IBA
01/2022 - 02/2017
5Insulin (Novolin)FDA Link
01/2021 - 01/2007
5Phosphotransferases (Kinase)IBA
01/2018 - 08/2004
4Neuroprotective AgentsIBA
08/2022 - 10/2017
4AntibodiesIBA
04/2022 - 01/2014
4IgYIBA
02/2022 - 01/2014
4Acetaminophen (Paracetamol)FDA LinkGeneric
01/2021 - 05/2016
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 02/2003
4EnzymesIBA
01/2021 - 01/2018
4Isoproterenol (Isoprenaline)FDA LinkGeneric
01/2021 - 09/2007
4Circular RNAIBA
01/2020 - 01/2019
4Reactive Oxygen Species (Oxygen Radicals)IBA
12/2018 - 04/2016
4Phenylephrine (Neo-Synephrine)FDA LinkGeneric
01/2018 - 11/2015
4sarcophine-diolIBA
09/2012 - 08/2007
3VaccinesIBA
02/2022 - 01/2016
3Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 04/2010
3Interleukin-2 (IL2)IBA
01/2022 - 01/2020
3Amino AcidsFDA Link
01/2022 - 02/2014
3abivertinibIBA
01/2022 - 11/2016
3Peptides (Polypeptides)IBA
11/2021 - 02/2013
3Small Interfering RNA (siRNA)IBA
01/2021 - 06/2017
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2021 - 01/2014
3Volatile Fatty AcidsIBA
01/2021 - 01/2021
3HDL LipoproteinsIBA
12/2020 - 12/2011
3DNA (Deoxyribonucleic Acid)IBA
10/2019 - 02/2008
3Triglycerides (Triacylglycerol)IBA
01/2019 - 04/2010
3RNA (Ribonucleic Acid)IBA
01/2019 - 07/2011
3AntigensIBA
01/2019 - 11/2006
3PhytochemicalsIBA
10/2018 - 01/2008
3Levodopa (L Dopa)FDA LinkGeneric
01/2018 - 11/2013
3Hormones (Hormone)IBA
01/2016 - 01/2012
3LeptinIBA
02/2014 - 05/2005

Therapy/Procedure

27Therapeutics
06/2022 - 06/2012
8Radiotherapy
12/2021 - 07/2015
5Aftercare (After-Treatment)
06/2022 - 11/2015
5Drug Therapy (Chemotherapy)
04/2021 - 04/2009
3Lasers (Laser)
03/2019 - 10/2014